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Figure S1. Design and operational components of the valveless SCBC design.  a.  The three 
dimensional mold for the elastomeric (PDMS) microfluidics layer, shown in side-view cross section.  
The drawing is not to scale, so as to illustrate some of the important features. SU8 and SPR220 
are photoresist materials that are patterned through a series of masking/photolithography steps to 
produce the structure shown.  b.  The clamp system used to partially  (Close I state) or fully close 
(Close II state), or hold open the conduits between the microchannels and the cell chamber.   
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Figure S2. Reproducibility of the ssDNA array. (a) Validation of the first layer of ssDNA array. The 
plot in the right shows the intensity of each stripe in the left figure, along the drawn vertical line. 3 
different ssDNA sequences were repetitively patterned in 20 channels. (b) Validation of the barcode 
array after the second flow patterning step. Each square unit of fluorescent spots represents many 
copies of a 3x3 array.  The plot at right provides the fluorescence intensity of the vertical line that is 
drawn through 2 of the square units. 
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Figure S3. The antibody microarray construction.  (a) Schematic illustration of the chemical 
pattering steps to produce the high-density ssDNA array. Stripes of DNA are first patterned onto a 
polylyscine-coated glass surface using a flow patterning mold oriented as shown in the lower left 
drawing of a.  A second similar flow patterning step, but oriented perpendicular to the first, is used 
to create unique DNA addresses at the intersections of the crossed stripes.  The color coded DNA 
oligomers in the drawing illustrate the patterning/hybridization sequence to produce the final array. 
(b) The addressibility of the individual spots within each array is illustrated in these images of 
different DNA patterns prepared as shown in (a).  In each case, a uniform, square array is 
patterned, but the but with unique DNA addresses at the different array spots.  Selective addition of 
a set of Cy3-complementary DNA oligomers is done to highight that the flexibility of this patterning 
approach. (c) The steps of the sandwich ELISA-like assay that is utilized for protein detection once 
the DNA array has been converted into an antibody array.
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Figure S4.   Calibration and Cross-reactivity analysis of antibody arrays.  a.  Calibration curves of 
P-EGFR, P-ERK, P-mTOR, P-Akt1, P-s6k, IL6 and VEGF using recombinant proteins. The number 
of copies of each protein in a microchamber is calculated by from the concentration of the stock 
solution within the 0.144 nanoliter volume of the microchamber.  These calibration curves were 
measured on an SCBC that was identical to those used for the experiments.  b. Cross-reactivity 
characterization of P-EGFR, P-ERK, P-mTOR, P-Akt1 and P-s6k. The ssDNA barcode array was 
printed using a standard DNA spotting system, but the ELISA-like immunoassays used for these 
studies were identical to those used in the experiments.  Cross-reactivity was <2% for all proteins 
in the panel.    
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Figure S5. Reading of a developed SCBC assay and automation of data processing. (a) The glass 
slide of an SCBC was scanned with an array scanner to extract the fluorescence intensity of the 
spots within each antibody array. The data shown here is visualized by an overlay image that was  
generated by a laboratory developed Matlab program.  Each square outlined region is a lattice unit, 
and each lattice unit contains between 20 and 25 cell microchambers (depending upon whether the 
SCBC was designed for cell lysis or not). (b) A single lattice unit, showing the actual fluorescence 
image of the developed protein assays from 25 microchambers. The array spots designated as  
alignment markers show up as green fluorescent squares. (c) The alignment markers are used to 
assign protein identities to each array element. The program identifies each cell chamber as a 
reading frame, and assigns the protein identity to each spot of a barcode.  Note that some proteins 
are assayed in duplicate.  
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Figure S6. Scatter plots showing fluorescent levels and correlations of the  assayed 
phosphoproteins from an SCBC measurement for two model GBM cell lines. Data from 0 cell 
(blue) and 1 cell (red) are superimposed to illustrate the baseline level. The samples used in 
this study are U87 cells (a), U87 cells stimulated with EGF (b) and U87 EGFRvIII cells (c). For 
each plot, the correlation coefficient between two phosphoproteins is provided.  The U87 cells 
are not constitutively activated, and so their phosphoprotein levels are expected to be less 
than those seen for the U87 EGFRIII cells.  EGF stimulation of the U87 cells activates those 
cells, and is expected to increase the levels of the assayed phospho-proteins.  
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Figure S7. Results of a control experiment in which the levels of the indicated secreted proteins were 
assayed from T cells following a 6 hour incubation time.  These non-adherent cells were screened from a 
healthy donor. They could move around during the course of the incubation.  Thus, even if the cells 
interact in a distance dependent fashion so as to influence the levels of these assayed proteins, that 
influence would be expected to be washed out.  Thus, no distance-dependence in the protein levels is 
expected, and non is observed. 
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Figure S8. Statistical analysis of SCBC data, 6 hour incubation experiment.  a. Average 
values of protein levels for  1- and 2-cell experiments.  The 2-cell experiments are given as a 
function of cell separation.  Calculated P-values are indicated. b.  Dot plot of  0-, 1-, 2-, and 3-cell 
data sets for each assayed protein.  The 2-cell data sets that represent the smallest and largest 
cell-cell separations are shown.    All data are from the same SCBC;  the 0-cell data represent an 
empty microchamber, and so provide a background measurement. The blue bar indicates the 
mean protein level at each condition. For both plots, P values are 0.05 (*), 0.01 (**) and 0.001 (***), 
with 0.05 considered statistically significant. An insignificant statistical difference (P>0.05) is 
denoted as NA. 
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Figure S9. Data from the minimal incubation time experiment.  a. Average protein levels, in 
copy numbers, as a function of cell-cell distance in the 2-cell experiments.  The average 
single-cell value (×2) is  provided for comparison.  b. Coordination of the 4 phospho-proteins 
for the  1-cell and cell separation dependent 2-cell experiments.   The pie charts represent the 
eigenvector compositions;  all 4 eigenvectors are shown, with eigenvalues given as relative 
amplitudes (in %). No obvious change of coordination is found for the various cell separations, 
or between the 1 cell and 2 cell experiments. Secreted proteins are not detected in these 
assays.
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Figure S10.  A histogram of the observation frequency of the experimentally measured cell 
separation distances (6 hour incubation experiment), compared against a simulated distribution 
generated by placing cells in random positions. A custom Matlab program was used to randomly 
generate ~90,000 cell pairs, and to calculate cell-cell distances. The simulation conditions were 
that the cells were wholly located within the same microchamber, and that they don't overlap.  The 
agreement between the simulation and the experiment indicates that the inhibitory and activating 
interactions measured at the functional protein level do not translate into attractions and repulsions 
that can influence cell-cell separation distance, at least on the 6 hour timescale of the experiment. 
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Figure S11.  Protein-specific cell-cell interaction functions.  These functions are obtained by fitting 
the measured protein level vs separation distance to the quadratic equation
f(LAB)=a+ b·LAB + c·LAB2, where a, b, and c are fitted constants, and LAB is the cell-cell distance.  
The protein copy numbers are from the 6 hour incubation,  2-cell experiments, and are normalized 
to 2x the average single cell experimental value (horizontal dashed line). 
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Name Sequence**
2X A-3’-polyA ATCCTGGAGCTAAGTCCGTAAAAAAAAAAAAAAAAAAAAAATCCTGGAGCTAAGTCCGTAAAAAAAAAAAAAAAAAAAAA
2X B-3’-polyA GCCTCATTGAATCATGCCTAAAAAAAAAAAAAAAAAAAAAGCCTCATTGAATCATGCCTAAAAAAAAAAAAAAAAAAAAA
2X C-3’-polyA GCACTCGTCTACTATCGCTAAAAAAAAAAAAAAAAAAAAAGCACTCGTCTACTATCGCTAAAAAAAAAAAAAAAAAAAAA
A'-D-D ATGGTCGAGATGTCAGAGTAAAAAAAAAAAATGGTCGAGATGTCAGAGTAAAAAAAAAAATACGGACTTAGCTCCAGGAT
D3' NH2-AAAAAAAAAAAAATACTCTGACATCTCGACCAT
B'-E-E ATGTGAAGTGGCAGTATCTAAAAAAAAAAAATGTGAAGTGGCAGTATCTAAAAAAAAAAATAGGCATGATTCAATGAGGC
E3' NH2-AAAAAAAAAAAAATAGATACTGCCACTTCACAT
C'-F-F ATCAGGTAAGGTTCACGGTAAAAAAAAAAAATCAGGTAAGGTTCACGGTAAAAAAAAAAATAGCGATAGTAGACGAGTGC
F3' NH2-AAAAAAAAAAAAATACCGTGAACCTTACCTGAT
A'-G-G GAGTAGCCTTCCCGAGCATTAAAAAAAAAAGAGTAGCCTTCCCGAGCATTAAAAAAAAAATACGGACTTAGCTCCAGGAT
G' NH2-AAAAAAAAAAAAAAATGCTCGGGAAGGCTACTC
B'-H-H ATTGACCAAACTGCGGTGCGAAAAAAAAAAATTGACCAAACTGCGGTGCGAAAAAAAAAATAGGCATGATTCAATGAGGC
H' NH2-AAAAAAAAAAAAACGCACCGCAGTTTGGTCAAT
C'-I-I TGCCCTATTGTTGCGTCGGAAAAAAAAAAATGCCCTATTGTTGCGTCGGAAAAAAAAAAATAGCGATAGTAGACGAGTGC
I' NH2-AAAAAAAAAAAAATCCGACGCAACAATAGGGCA
A'-J-J TCTTCTAGTTGTCGAGCAGGAAAAAAAAAATCTTCTAGTTGTCGAGCAGGAAAAAAAAAATACGGACTTAGCTCCAGGAT
J' NH2-AAAAAAAAAAAAACCTGCTCGACAACTAGAAGA
B'-K-K TAATCTAATTCTGGTCGCGGAAAAAAAAAATAATCTAATTCTGGTCGCGGAAAAAAAAAATAGGCATGATTCAATGAGGC
K' NH2-AAAAAAAAAAAAACCGCGACCAGAATTAGATTA
C'-L-L GTGATTAAGTCTGCTTCGGCAAAAAAAAAAGTGATTAAGTCTGCTTCGGCAAAAAAAAAATAGCGATAGTAGACGAGTGC
L' NH2-AAAAAAAAAAAAAGCCGAAGCAGACTTAATCAC
Table S1. Sequences of ssDNA oligmers and terminal functionalization.*
* All oligonucleotides were synthesized by Integrated DNA Technology (IDT) and purified 
via high performance liquid chromatography (HPLC).
** Purple color sequences are anchored to the glass surface as the first layer of the ssDNA 
array. Red color sequences are briding sequences to the complementary purple color 
sequences.  The blue color sequences are used to conjugate DNA-labeled antibodies.
Supporting Tables
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DNA label Antibody (vendor: clone) Source
D mouse anti‐hu phospho‐EGF R 
biotin‐labeled goat anti‐hu EGF R
R&D Y1068
R&D BAF231
E anti‐hu phospho‐ERK kit R&D DYC1825
F anti‐IL 6 kit R&D DYC206
G anti‐hu phospho‐mTOR kit R&D DYC1665
I anti‐hu phospho‐Akt1 kit R&D DYC2289
K anti‐VEGF kit R&D DYC293B
L anti‐hu p70 s6 kinase  R&D DYC896
Table S2. List of antibodies used for GBM cell proteomic assay.
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P‐EGFR P‐ERK IL6 P‐Akt VEGF P‐s6k
P‐EGFR 1.00 0.72 0.45 0.66 0.50 0.63
P‐ERK 1.00 0.49 0.72 0.63 0.67
IL6 1.00 0.43 0.49 0.31
P‐Akt 1.00 0.62 0.70
VEGF 1.00 0.74
P‐s6k 1.00
Table S3a. 6 hour incubation, 0-30 µm separation
Table S3.  Protein-protein correlation coefficients in EGFRvIII cells for varying incubation times and cell-
cell separation distances.  All measurements from 2-cell assays and from molecule copy number.
>120 um P‐EGFR P‐ERK IL6 P‐Akt VEGF P‐s6k
P‐EGFR 1.00 0.81 0.67 0.63 0.64 0.62
P‐ERK 1.00 0.77 0.73 0.74 0.67
IL6 1.00 0.53 0.52 0.44
P‐Akt 1.00 0.73 0.74
VEGF 1.00 0.77
P‐s6k 1.00
Table S3b. 6 hour incubation, >120 µm separation
Table S3d. 30 min incubation, 0-30 mm separation
0‐30 um P‐EGFR P‐ERK P‐Akt P‐s6k
P‐EGFR 1.00 0.09 0.11 0.21
P‐ERK 1.00 0.39 0.26
P‐Akt 1.00 0.47
P‐s6k 1.00
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Table S3e. 30 min incubation, >120 mm separation
P‐EGFR P‐ERK P‐Akt P‐s6k
P‐EGFR 1.00 0.52 0.29 0.30
P‐ERK 1.00 0.21 0.28
P‐Akt 1.00 0.45
P‐s6k 1.00
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Supporting Materials and Methods 
General microchip fabrication steps. Microchips were used for antibody array flow patterning 
and for the single cell barcode chips.  For both, standard photolithographic techniques were used 
to prepare a hard mold from which the elastomer component of the final microchip was cast.  To 
this purpose, 5” chrome lithography masks were designed with AutoCAD 2007 (Autodesk Inc.) 
and printed out by UCLA Nanolab foundry. The features on the chrome mask were used to 
pattern SU8 and/or SPR220 photoresist on a 4” silicon wafer. For the flow patterning molds, the 
photoresist thickness, which translates into the height of the flow channels, was 25 µm. For the 
SCBC chips, multiple masking steps using two different photoresists produced a mold with 
three-dimensional structure, as shown in Figure S1.   
Antibody array preparation. The approach for antibody array preparation was previously used 
for the high resolution patterning of cells and tissues.1 It is used here for the preparation of 
miniature 3×3 antibody arrays for protein capture.  The arrays are initially patterned as DNA 
arrays, since DNA has the physical and chemical stability to withstand the various processing 
steps of microfluidics fabrication.  The DNA itself is patterned onto a polylysine coated glass 
slide using two sequential microchannel-based flow patterning steps (Figure S2).  The first flow 
patterning step generates 20 m wide, 50 m pitch lines of 3 unique DNA oligomers, while the 
second DNA patterning step, using a similarly structured mold, is carried out at right angles to 
the first.  The actual antibody array is formed at the intersection of the two sets of lines. 
Substantially smaller and denser features are possible with this approach.1 The trick is to choose 
the right sets of DNA oligomers in the two patterning steps so that, at the intersection of 3 
bottom lines and 3 top lines, a 9 element array of uniquely addressable ssDNA oligomers is 
formed. Those unique addresses are then used as assembly locations for antibodies that have 
been labeled with complementary ssDNA’ oligomers.  All DNA and antibody reagents used are 
provided in Supporting Tables S1 and S2.  
For the first flow patterning step, a PDMS mold containing 20 channels was used to flow pattern 
three distinct 80-mer ssDNA “anchor” strands (A, B, C; 266 µM in 33% DMSO) in adjacent sets 
of three channels (one distinct strand per channel), to produce 6 2/3 complete sets of lines 
(Figure S2). The microchip was then incubated in a humidified environment for one day, before 
exposure to 2.5 mW UV light for 5 min to crosslink the DNA/polylysine film.  The chip is then 
incubated at room temperature for 1 day and the glass slide was separated from the PDMS.  The 
surface was and rinsed sequentially with 0.02% SDS in PBS (2×), followed by PBS and 
deionized (DI) water. The slide was dried under flowing N2.   
A second microfluidics flow patterning step was then carried out at right angles to the first.  
Again, a 20 channel mold was used, making up 6 2/3 repeats of 3 adjacent microchannels that 
carried distinct DNA solutions - in this case, each solution was comprised of three distinct 
ssDNA “bridge” oligomers (A’-i, B’-ii, …). Each bridge oligomer includes a 20-base pair tail 
that is complementary to one of the three anchor sequences, and a 20-base pair head with a 
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unique sequence.  As such, once the flow-patterning was complete, the resultant 3 × 3 arrays 
(Figure S3) contained nine spatially addressable oligonucleotide head sequences (i–ix) that were 
available to bind distinct capture antibodies conjugated to one of nine complementary ssDNA 
strands (i’–ix’).   For this patterning step, three patterning solutions were constructed from 3 
separate 150 M DNA solutions in 1% BSA. Solutions were infused into the microchannels. The 
microchip was incubated for 2 hours to allow the arrays to assemble via DNA hybridization, 
followed by injection of 3% PBS/BSA to wash out residual DNA in microchannels. The 
microchip was disassembled, and a rinsing procedure identical to that for the first flow patterning 
step was used. The patterned slides were preserved in a desiccator for no more than 2 month.   
DNA array validation. The patterned DNA array was validated by first blocking it with  3% 
bovine serum albumin (BSA) in PBS for 1 h at room temperature. The blocking reagent was 
replaced by 100 nM cy5 conjugated complementary DNA oligomers, and the slide was incubated 
for another hour at 37 °C. The slide was rinsed with 3% BSA in PBS twice and DI water, and 
dried under flowing N2.  It was then scanned by a Genepix scanner (Molecular Devices, LLC.) 
(Figure S3). The validation procedure provides a check on the cross-reactivity between the 
anchor, bridging, and terminal ssDNA oligomers.  In addition, the fluorescence intensity per unit 
area can be compared against standard DNA spotting approaches as a means of gauging surface 
coverage.  Finally, it provides an assessment of the fidelity of the microfluidics flow-patterning 
steps.   
Antibody array calibration and cross reactivity characterizations. Procedures for calibration 
and cross-reactivity characterizations of our barcode assays have been described before1, 2. We 
used recombinant IL6, VEGF, p-EGFR, p-ERK, p-Akt and p-s6k and p-mTOR proteins (R&D 
Systems, Inc.) at various concentrations (Figure S4a) to calibrate the fluorescence intensity of a 
barcode assay with molecule number in a cell chamber with a volume of 0.144 nl. These 
calibrations were executed in a fashion identical to a standard SCBC experiment, except that the 
recombinant protein solutions were added in place of the cells.  Antibody cross-reactivity assays 
(Figure S4b) were carried out using arrays comprised of identical biomolecular reagents, but 
prepared via spotting procedures, rather than through flow patterning.  All antibody reagents 
used are listed in Table S2.  
SCBC fabrication. The SCBC chip is a single elastomer microfluidics layer bonded on top of 
the barcode-patterned glass slide.  The elastomeric layer mold was patterned in several steps.  A 
side view that shows the essential patterned features for structural support, cell microchambers, 
and microchannels, is shown in Figure S1. The cell microchambers are designed so that their 
volume is minimized.  Each microchamber is 170 × 170 m, and 16 µm high.  
Cell sample preparation. U87 cells were purchased from American Tissue Culture Collection 
(ATCC). U87 EGFRvIII cells were constructed as reported3, 4. The cells were cultured in DMEM 
(ATCC) medium supplemented with 10% fetal bovine serum (FBS) in a 5% CO2 incubator at 
37 °C. Cells were trypsinized and subcultured every two days. Cells were concentrated to 
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1×105/ml in a volume of at least 100 µl. To facilitate cell imaging and counting, cells were 
stained with 5 µM CMFDA in PBS for 10 min, and re-suspended with a desired concentration.  
Cell viability, estimated at 95%, was be confirmed by visual inspection of the cells within the 
chambers, since the live U87 EGFRvIII cells spread out and retaining the CMFDA dye within 
their membrane.   
SCBC operation. The mating surface of a molded PDMS layer for the single cell barcode 
microchip was rendered hydrophilic by an O2 plasma etcher (Quorum Technologies Ltd.), and 
aligned by eye and mated onto a barcoded glass slide. Such imprecise alignment is effective 
because the DNA barcode arrays are patterned at such high density, relative to the size of the 
microchambers, that each microchamber is ensured of overlapping with at least one complete 
barcode. The microchannels were blocked with 3% BSA in PBS for 1 h, and filled with 10 µg/ml 
antibody-DNA conjugates (Table S2).5 After incubation at 37 °C for 1 h, unlinked conjugates 
were washed off and replaced by 3% BSA in PBS. At the point, the ssDNA array has been 
transformed into an antibody array. The SCBC is then mounted onto a clamp (Figure 1b). Cells 
at a concentration of 1×106 per ml were loaded onto the microchip by pipetting through the inlet 
ports on the SCBC, with no pressure from the clamp. Then cells were distributed randomly to the 
microchambers. Pressure was then adjusted to encapsulate cells within the microchambers (Close 
I and II states are both sufficient).  
After the U87 EGFRvIII cells were loaded to the SCBC, the clamp pressure was adjusted to the 
Close II state (Figure 1b). For the minimal incubation time experiment, we imaged all cell 
chambers using a fluorescence microscope.  That process took 30 minutes. Then a 3× lysis buffer 
(20 mM Tris-HCl, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium 
pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, and 1 µg/ml leupeptin; Cell 
Signaling) supplemented with protease/phosphatase inhibitor cocktail (Cell Signaling) was 
injected into the microchannels, and the clamp was adjusted to the Close I state, which permits 
introduction of lysis buffer into each cell chamber, but doesn’t permit cell escape. The SCBC 
was incubated at room temperature with mild shaking for 2 h.  The lysis buffer was then 
removed by flowing PBS for 15 min. 
For the 6 hr incubation experiments, cells were loaded and the clamp was adjusted to the Close II 
state, after which the clamped SCBC was incubated at 37 °C for 6 h in a CO2 incubator. Then all 
cell chambers were imaged using a fluorescence microscope, and the remaining steps were 
identical to those described for the minimal incubation time experiment.   
In order to localize the position of each unit of microchambers, a staining solution containing 20 
µM Alexa 514 succinimidyl ester (Molecular Probes, Inc.) was used to label microchannels for 
10 min under the Close II state. Dye residue was removed by injecting 3% BSA in PBS and 
incubated for 20 min. The clamp was then release to form the open state, and biotinylated 
detection antibody (R&D systems, Cell signaling) cocktails in 1:200 dilution prepared according 
to product instruction was injected into the microchannels. After a 2 hr incubation with mild 
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shaking, the antibody solution was cleaned by 3% BSA in PBS, and a solution comprised of 1 
µM cy5-Streptavidin and 100 nM H-cy3 in PBS with 3% BSA was used to develop the barcode 
arrays. The glass slide containing the developed arrays was detached from the PDMS, and 
cleaned for further scanning. 
Assay quantification and statistics. Developed barcode slides were scanned with an Axon 
GenePix 4400A (Molecular Devices) with setting of: (for cy5 dye, 635 nm) laser power 80%, 
optical gain 600; (for cy3 dye, 532 nm) laser power 15%, optical gain 450 for 532 nm. The 
resultant images were digitized at 16 bits (scale of 0-65535). For data analysis, the GenePix Pro 
software exported the digitized fluorescence image to a custom algorithm, written in Matlab 
(MathWorks, Inc.), that automated the process (Figure S5) of associating the individual array 
spots with microchamber address labels and protein identification tags.     
Statistical analysis was performed using laboratory developed Matlab (Mathworks) programs 
and Prism (GraphPad Software). To compare protein levels under various conditions, we 
obtained the mean protein number, and used P value to evaluate the whether the difference was 
significant through two-tailed Student's t tests assuming unequal variance. A P value less than 
0.05% is considered statistically significant and denoted with *, while ** and *** represent 
P<0.01 and P<0.001, respectively.  The error bars for mean protein levels represent the standard 
error of the mean, which is the standard deviation of the mean protein level divided by square 
root of cell number. This type of analysis was carried out to establish the statistical uniqueness of 
the 0, 1, 2, and 3 cell data sets, as well as the uniqueness of the different 2 cell data sets, as a 
function of cell-cell separation (Figure S6). 
Signaling coordination analysis. For a given set of experimental conditions (e.g. 2 cells, 6 hour 
incubation, 30-60 m separation) the corresponding protein assays were converted into copy 
numbers detected, and the protein-protein covariance matrix was calculated and diagonalized 
using Matlab functions. This yielded 6 eigenvectors and 6 eigenvalues (Figure 2 and Figure S8).  
Two-cell distribution simulations. We simulated the placement of the cells in 2-cell 
experiments to interrogate whether their locations were influenced through the inhibitory or 
activating interactions.  An elliptic shaped cell of dimensionsg  25 m x 7.5 m provided a 
mimic of the adherent U87 cells. The program randomly sets the position of the first cell, and 
then generates the second cell in a random position, with the conditions that both cells are within 
the same microchamber, and the cells do not overlap. We simulated 90,000 cell pairs, and then 
measured the distances between the cells, from from cell-center to cell-center. These distances 
were binned into 5 groups, and compared with experimental result (Figure S9).     
Simulations of protein levels from 3-cell microchamber experiments. For these simulations, 
we first fitted the 6 hour incubation, two-cell microchamber data of Figure 2a to   
  , where a, b and c are protein-specific fitted constants and L is the 
cell-cell distance.  Those fits are provided in Figure S10.  The plotted data is normalized by the 
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average value for that protein from the one-cell experiments (the dashed, horizontal line of 
Figure S10).   
A custom written Matlab program was written for simulating 3-cell experiments.  Each cell was 
modeled as a 25 m x 7.5 m ellipse to provide a mimic of an adherent cell. Three cells were 
randomly placed within a microchamber, with the conditions of zero cell-cell overlap, and that 
each cell was fully contained within the microchamber walls. The program generated ~12,000 
three cell data sets, and computed the distances between each cell pair, using the center of the 
ellipse to define the cell location.  The algorithm for calculating individual protein levels was:  
a. The protein levels for each of the three cells, A, B, and C, are initially set to the corresponding 
average from the single cell experiments.  This is the y-axis value of ‘1’ on Figure S10.  
b. Based upon the fitted protein-specific distance functions, the pairwise interactions for A-B, B-
C, and C-A are calculated.  As an example, from Figure S10, if A-B are separated by 40 m, 
then p-EGFR is inhibited by a factor of 0.69 for each cell.  If A-C are separated by 90 m, then 
p-EGFR is activated by a factor of 1.17.  Multiplying these two factors together gives the 
normalized amount of p-EGFR for A (=0.81).  Next this procedure is repeated for cell B and 
lastly for cell C.  The amount of protein estimated for this 3-cell experiment is the sum over all 3 
cells.  The result is independent of which cells are labeled A, B and C. This procedure is done for 
each protein, and for each one the result is averaged for all ~12,000 simulated 3-cell experiments 
to produce the predictions of Figure 3.  
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